Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions |
umls-concept:C0005767,
umls-concept:C0005910,
umls-concept:C0028754,
umls-concept:C0032105,
umls-concept:C0032145,
umls-concept:C0040044,
umls-concept:C0202098,
umls-concept:C0205307,
umls-concept:C0205345,
umls-concept:C0441655,
umls-concept:C0441889,
umls-concept:C0681850,
umls-concept:C1550501,
umls-concept:C1706203,
umls-concept:C1707520,
umls-concept:C2349001,
umls-concept:C2697811
|
pubmed:issue |
3
|
pubmed:dateCreated |
1986-3-31
|
pubmed:abstractText |
This study was undertaken to obtain further information on the mechanism by which blood fibrinolytic activity, a balance between plasminogen activators and inhibitors, is lowered in obese subjects. Fasting blood samples were collected from 35 subjects, aged 15 to 45 years, with normal glucose tolerance and a Body Mass Index (BMI) varying widely between 16 and 45 (normal, 19 to 25). Euglobulin Fibrinolytic Activity (EFA) did not correlate with the level of tissue type plasminogen activator (t-PA) related antigen but exhibited a negative correlation with the level of PA inhibitor (r = -.609, P less than 0.01). EFA was negatively and PA inhibitor positively correlated with both BMI (r = -.381, P less than 0.02 and .664, P less than 0.01, respectively) and plasma insulin level (r = .410, P less than 0.02 and .521, P less than 0.01, respectively). Stepwise analysis showed that these correlations were independent. As expected, plasma insulin was correlated with BMI (r = .512, P less than 0.01) and triglyceride level (r = .38, P less than 0.02), total cholesterol with age (r = .379, P less than 0.02). Ten obese subjects were submitted to a 24-hour fast. While body weight did not change appreciably, plasma insulin decreased from 22.3 +/- 2.2 to 16.3 +/- 1.1 microU/ml, EFA increased from 3.6 +/- .8 to 4.9 +/- .67 mm, and PA inhibitor decreased from 4.52 +/- .76 to 3.44 +/- .63 IU/mL. All these differences were significant. T-PA-related antigen did not change.(ABSTRACT TRUNCATED AT 250 WORDS)
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Glycoproteins,
http://linkedlifedata.com/resource/pubmed/chemical/Insulin,
http://linkedlifedata.com/resource/pubmed/chemical/Plasminogen Inactivators,
http://linkedlifedata.com/resource/pubmed/chemical/Serum Globulins,
http://linkedlifedata.com/resource/pubmed/chemical/Tissue Plasminogen Activator
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0026-0495
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
35
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
250-3
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:3081778-Adolescent,
pubmed-meshheading:3081778-Adult,
pubmed-meshheading:3081778-Body Weight,
pubmed-meshheading:3081778-Female,
pubmed-meshheading:3081778-Fibrinolysis,
pubmed-meshheading:3081778-Glycoproteins,
pubmed-meshheading:3081778-Humans,
pubmed-meshheading:3081778-Insulin,
pubmed-meshheading:3081778-Male,
pubmed-meshheading:3081778-Middle Aged,
pubmed-meshheading:3081778-Obesity,
pubmed-meshheading:3081778-Plasminogen Inactivators,
pubmed-meshheading:3081778-Serum Globulins,
pubmed-meshheading:3081778-Tissue Plasminogen Activator
|
pubmed:year |
1986
|
pubmed:articleTitle |
Correlation between blood fibrinolytic activity, plasminogen activator inhibitor level, plasma insulin level, and relative body weight in normal and obese subjects.
|
pubmed:publicationType |
Journal Article
|